AT&T yields 4.37% and Verizon yields 5.78%, both with covered dividends. Verizon has raised its payout for 20 consecutive years.
Pfizer leads the group with a 6.18% yield at ~$28 per share, but GAAP earnings are thin, and coverage relies on adjusted EPS of $2.80 to $3.00.
A $3,000 spread across all three stocks generates roughly $165 in annual passive income at a blended 5.50% yield, with full same-day liquidity.
Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Verizon made the cut. Enter your email to see the other nine names and why VZ earned its spot. The report is free. Enter your email and see the full list.
Blue-chip dividend-paying stocks don’t always demand blue-chip checks. Three of the largest dividend names on the New York Stock Exchange — AT&T(NYSE:T), Verizon Communications(NYSE:VZ) and Pfizer(NYSE:PFE) — all trade below $50 a share, which puts a meaningful position within reach of a $1,000 stake. Spread $1,000 across each name and a $3,000 outlay throws off roughly $160 in annual passive income at current yields.
24/7/ Wall St.
Here is the framing readers deserve before the ticker profiles: A low share price speaks only to entry cost, while valuation is a separate question. A $25 stock is not inherently better value than a $250 stock, and share count alone tells you nothing about the underlying business. What earns these three a look in an income portfolio is cash-flow generation and the coverage sitting behind each payout.
Here is what a $1,000 stake in each of these 3 high-yield names would generate in annual income, running in countdown order by forward yield.
Free Report, Just Released
Why VZ Made Our Top 10 List
24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.
And VZ made the cut. See who else did.
The report is free, and you can see why we think each stock is a top investment today.
AT&T is the wireline-and-wireless carrier rebuilt around its Advanced Connectivity segment, where service revenue grew 5.1% in Q2 2026 with operating income up 20.3% to $7.34 billion. The company reached 38.6 million fiber locations and is targeting 40 million by end of 2026 and more than 60 million by 2030. The yield sits at this level because a capital-intensive fiber buildout and $144B of debt cap the share price, while the payout itself remains covered.
Coverage looks solid. Full-year adjusted EPS guidance remained $2.25 to $2.35 against a $1.11 annualized payout, and CFO Pascal Desroches said “Our cash flow and liquidity provides us with flexibility to sustain our dividend and accelerate our planned buybacks.” MarketWatch flagged the stock as the smartest bet in the wireless sector on Sept. 21.
T Analyst Ratings — 24/7 Wall St.
Stock #2: Verizon Communications
Yield: 5.78%
Shares for $1,000: ~21.55 (at $46.40)
Annual Passive Income: ~$61
Verizon closed the Frontier acquisition on Jan. 20, pushing fiber connections to 10.9 million (+43.3%) and lifting total broadband to ~17.1 million (+34.5% YoY). Net unsecured leverage sits at 2.5x after that deal, which is the structural reason the yield trades this high on a business generating its “highest ever reported adjusted EBITDA performance.”
The payout is covered. 2026 adjusted EPS guidance was raised to $4.99 to $5.04 against a $2.83 annualized dividend, and free cash flow is guided to $21.94 billion to $22.14 billion. CEO Dan Schulman put it plainly: “The dividend is still ironclad for us, and we raised the dividend.” The January hike marked the 20th consecutive year of dividend increases.
VZ Analyst Ratings — 24/7 Wall St.
Stock #3: Pfizer
Yield: 6.16% (ultra-high-yield)
Shares for $1,000: ~35.79 (at $27.94)
Annual Passive Income: ~$61.60
Pfizer is the ultra-high-yielder in this group, and it earns the hardest coverage look. The patent-cliff overhang, COVID-19 revenue rolloff (Comirnaty -59%, Paxlovid -63%), and a weak share price have pushed the yield well above the pharma sector norm. Launched and acquired products carried the quarter, growing 18% operationally, with contributions from Eliquis, Padcev, the Vyndaqel family and Ibrance.
On the dividend, 2026 adjusted EPS guidance of $2.80 to $3.00 covers the $1.72 annualized payout on adjusted earnings, and management raised the revenue midpoint to $60.5 billion to $62.5 billion. Chairman and CEO Albert Bourla was blunt in the Q2 call: “We feel extremely confident that we will, even the most stretched scenarios that we are running, we will be able to maintain our dividend.” The reported GAAP EPS is thin, so this is an adjusted-earnings coverage story built on a GAAP-thin base.
PFE Analyst Ratings — 24/7 Wall St.
Summary Table
Putting the Cash Flow Together
Combined, these three positions generate roughly $166.80 in annual passive income on a $3,000 investment based on a blended yield of around 5.45%. AT&T contributes about $44.20, Verizon adds about $61 and Pfizer rounds out the group with about $61.60.
Reinvest the quarterly checks and the compounding effect from three payers dropping cash into the account on staggered calendars starts to show up inside a couple of years. Unlike rental property or private credit, any of these positions can be trimmed or exited on a single trading day, which is the flexibility income investors actually pay for.
Got $1,000? VZ Made Our Top 10 List. Here’s Who Else Did
If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And VZ was one of them.
They combed the entire market. It’s not 10 ideas, not 10 stocks everyone is talking about, it’s what their research points to as the 10 best stocks to buy right now, and it’s free. Read more here and see which stocks made the list –>>
